Agile Vaccine Group

The Agile Vaccine Group is a cross-functional team of intramural/extramural researchers, clinicians, and scientists with a goal of developing novel vaccines using a standard platform.

The Agile Vaccine Group is a cross-functional team of intramural/extramural researchers, clinicians, and scientists with a goal of developing novel vaccines using a standard platform. The group is led by Dr. John Sanders and Dr. Tom Wierzba, with support from the IDEAS group for analytics and the Section’s clinical trials program for translational vaccine evaluation. This collaboration includes members of:

Some areas of vaccine development include:

  • Campylobacter (Campylobacteriosis)
  • Enterotoxigenic E. coli
  • UroPathogenic E. coli
  • SARS-CoV-2
  • Neisseria gonorrhoeae
  • Monkeypox

Vaccine from a vial being drawn into a syringe.

Photo by Mat Napo on Unsplash